1 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 23596104 | Prospective phase II Study on 5-days azacitidine for treatment of symptomatic and/or erythropoietin unresponsive patients with low/INT-1-risk myelodysplastic syndromes. | 2013 Jun 15 | 1 |